PSDV - EyePoint Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2018)Next Year (2019)
No. of Analysts4444
Avg. Estimate-0.15-0.15-0.58-0.51
Low Estimate-0.17-0.17-0.67-0.66
High Estimate-0.14-0.13-0.53-0.43
Year Ago EPS0-0.15-0.52-0.58
Revenue EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2018)Next Year (2019)
No. of Analysts4444
Avg. Estimate510k540k2.01M5.19M
Low Estimate400k440k1.71M2.8M
High Estimate610k600k2.23M9.59M
Year Ago Sales5.97M590k7.54M2.01M
Sales Growth (year/est)-91.50%-8.50%-73.30%158.20%
Earnings History12/30/20163/30/20176/29/20179/29/2017
EPS Est.-0.18-0.15-0.15-0.15
EPS Actual0-0.15-0.16-0.15
Difference0.180-0.010
Surprise %100.00%0.00%-6.70%0.00%
EPS TrendCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2018)Next Year (2019)
Current Estimate-0.15-0.15-0.58-0.51
7 Days Ago-0.15-0.15-0.58-0.51
30 Days Ago-0.15-0.15-0.58-0.51
60 Days Ago-0.15-0.14-0.57-0.48
90 Days Ago-0.15-0.15-0.591.16
EPS RevisionsCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesPSDVIndustrySectorS&P 500
Current Qtr.N/AN/AN/A0.42
Next Qtr.N/AN/AN/A0.38
Current Year-11.50%N/AN/A0.20
Next Year12.10%N/AN/A0.10
Next 5 Years (per annum)N/AN/AN/A0.12
Past 5 Years (per annum)N/AN/AN/AN/A